在研发I期和 II期，根据被试者的反馈，mRNA剂量是有调整的，导致诱发的刺突蛋白 --> 抗体滴度在合理范围之内。

来源: 唐宋韵于 2025-08-10 10:11:58 [博客] [旧帖] [给我悄悄话] 本文已被阅读：次

WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.